I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies shaping the industry. Today, we’ll dive into the exciting world of diabetes and cardiovascular health treatments,
In a world where medical breakthroughs often lag behind the urgent needs of patients, the fight against amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease (MND), stands as a stark reminder of the challenges ahead. This devastating condition, which progressively
The European Medicines Agency (EMA) has recommended the approval of Moderna's LP.8.1-adapted COVID-19 vaccine to address the challenges posed by the SARS-CoV-2 variant LP.8.1. Following the guidance of EMA's Emergency Task Force, the formulation of Spikevax has been tailored to combat the current
Pridopidine, an investigational therapy developed for Huntington's disease, recently faced a significant hurdle when the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended against its approval. This decision poses a challenge as it influences the European
Emerging as a groundbreaking innovation in biomedical sciences, Organ-on-Chips (OoC) technology has begun to transform traditional approaches to drug research and development. At the forefront of this revolution, these microengineered devices offer a physiological simulation of human organs,
In the ever-evolving landscape of biotechnology and pharmaceuticals, Ivan Kairatov stands as a respected authority, particularly in tech and innovation within the biopharma sector. He joins us today to discuss recent developments concerning a compound known as inidascamine. Originally developed by
